A Detailed Analysis of the Pancreatic Elastase Testing Market Based on the Rising Prevalence of Pancreatic Disorders, and Advancements in Diagnostics
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 186
Report ID: PMRREP33951
1. Executive Summary
1.1. Global Pancreatic Elastase Testing Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Type Lifecycle Analysis
2.4. Pancreatic Elastase Testing Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Pancreatic Elastase Testing Market Outlook: Product Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
3.3.3.1. Immunoassay kits
3.3.3.2. ELISA kits
3.3.3.3. Chemiluminescence immunoassay kits
3.3.3.4. Fluorescence immunoassay kits
3.3.3.5. Others (e.g., turbidimetric immunoassay kits)
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Pancreatic Elastase Testing Market Outlook: Application
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.5.3.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
3.5.3.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
3.5.3.3. Research and development purposes
3.6. Market Attractiveness Analysis: Application
3.7. Global Pancreatic Elastase Testing Market Outlook: Indication
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
3.7.3.1. Chronic Pancreatitis
3.7.3.2. Type 1 Diabetes
3.7.3.3. Cystic Fibrosis
3.7.3.4. Others
3.8. Market Attractiveness Analysis: Indication
3.9. Global Pancreatic Elastase Testing Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. Hospitals
3.9.3.2. Diagnostics Laboratories
3.9.3.3. Specialty Clinics
3.10. Market Attractiveness Analysis: End User
4. Global Pancreatic Elastase Testing Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product Type
5.3.3. By Application
5.3.4. By Indication
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
5.5.1. Immunoassay kits
5.5.2. ELISA kits
5.5.3. Chemiluminescence immunoassay kits
5.5.4. Fluorescence immunoassay kits
5.5.5. Others (e.g., turbidimetric immunoassay kits)
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.6.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
5.6.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
5.6.3. Research and development purposes
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
5.7.1. Chronic Pancreatitis
5.7.2. Type 1 Diabetes
5.7.3. Cystic Fibrosis
5.7.4. Others
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. Hospitals
5.8.2. Diagnostics Laboratories
5.8.3. Specialty Clinics
5.9. Market Attractiveness Analysis
6. Europe Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product Type
6.3.3. By Application
6.3.4. By Indication
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
6.5.1. Immunoassay kits
6.5.2. ELISA kits
6.5.3. Chemiluminescence immunoassay kits
6.5.4. Fluorescence immunoassay kits
6.5.5. Others (e.g., turbidimetric immunoassay kits)
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.6.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
6.6.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
6.6.3. Research and development purposes
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
6.7.1. Chronic Pancreatitis
6.7.2. Type 1 Diabetes
6.7.3. Cystic Fibrosis
6.7.4. Others
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. Hospitals
6.8.2. Diagnostics Laboratories
6.8.3. Specialty Clinics
6.9. Market Attractiveness Analysis
7. East Asia Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Application
7.3.4. By Indication
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
7.5.1. Immunoassay kits
7.5.2. ELISA kits
7.5.3. Chemiluminescence immunoassay kits
7.5.4. Fluorescence immunoassay kits
7.5.5. Others (e.g., turbidimetric immunoassay kits)
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.6.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
7.6.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
7.6.3. Research and development purposes
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
7.7.1. Chronic Pancreatitis
7.7.2. Type 1 Diabetes
7.7.3. Cystic Fibrosis
7.7.4. Others
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. Hospitals
7.8.2. Diagnostics Laboratories
7.8.3. Specialty Clinics
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Application
8.3.4. By Indication
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
8.5.1. Immunoassay kits
8.5.2. ELISA kits
8.5.3. Chemiluminescence immunoassay kits
8.5.4. Fluorescence immunoassay kits
8.5.5. Others (e.g., turbidimetric immunoassay kits)
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.6.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
8.6.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
8.6.3. Research and development purposes
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
8.7.1. Chronic Pancreatitis
8.7.2. Type 1 Diabetes
8.7.3. Cystic Fibrosis
8.7.4. Others
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. Hospitals
8.8.2. Diagnostics Laboratories
8.8.3. Specialty Clinics
8.9. Market Attractiveness Analysis
9. Latin America Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By Indication
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
9.5.1. Immunoassay kits
9.5.2. ELISA kits
9.5.3. Chemiluminescence immunoassay kits
9.5.4. Fluorescence immunoassay kits
9.5.5. Others (e.g., turbidimetric immunoassay kits)
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.6.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
9.6.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
9.6.3. Research and development purposes
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
9.7.1. Chronic Pancreatitis
9.7.2. Type 1 Diabetes
9.7.3. Cystic Fibrosis
9.7.4. Others
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. Hospitals
9.8.2. Diagnostics Laboratories
9.8.3. Specialty Clinics
9.9. Market Attractiveness Analysis
10. Middle East & Africa Pancreatic Elastase Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By Indication
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
10.5.1. Immunoassay kits
10.5.2. ELISA kits
10.5.3. Chemiluminescence immunoassay kits
10.5.4. Fluorescence immunoassay kits
10.5.5. Others (e.g., turbidimetric immunoassay kits)
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.6.1. Diagnosis of pancreatic disorders (e.g., chronic pancreatitis)
10.6.2. Monitoring of pancreatic function (e.g., after pancreatic surgery)
10.6.3. Research and development purposes
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
10.7.1. Chronic Pancreatitis
10.7.2. Type 1 Diabetes
10.7.3. Cystic Fibrosis
10.7.4. Others
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. Hospitals
10.8.2. Diagnostics Laboratories
10.8.3. Specialty Clinics
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. DiaSorin
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. ScheBo Biotech AG
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Immundiagnostik AG
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Invivo Healthcare
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. DRG Instruments GMBH
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Verisana Laboratories
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. BÜHLMANN Laboratories AG
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. CerTest Biotec S.L.
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. R-Biopharm AG
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. American Laboratory Products Company, Ltd.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Vitassay Healthcare, S.L.U.
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
